GeoVax Labs ( (GOVX) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GeoVax Labs, Inc. has filed a Form 12b-25, notifying investors of a delay in submitting its Form 10-K (Yearly Report) for the fiscal year ended December 31, 2025. The company is late on its annual filing but remains current on all other required periodic reports over the past 12 months.
Management says the Form 10-K (Yearly Report) cannot be filed on time without unreasonable effort or expense, citing delays in compiling and reviewing information for inclusion in the report. There is no mention of auditor changes, governance issues, or regulatory investigations as drivers of the delay.
GeoVax expects to file the delayed Form 10-K (Yearly Report) within the standard 15-calendar-day extension allowed under SEC Rule 12b-25. This suggests investors should anticipate the annual report to be submitted by mid-April 2026, assuming no further complications.
The company anticipates reporting a net loss of about $21.5 million for 2025, an improvement from the $25 million net loss reported for 2024. While this signals a narrower loss, investors should treat this as preliminary and subject to change once the full audited statements and detailed disclosures are filed.
The notification emphasizes that GeoVax is working to complete its reporting obligations promptly and in compliance with SEC rules. The Form 12b-25 was signed on March 31, 2026, by Chief Financial Officer Mark W. Reynolds, underscoring executive-level oversight of the delayed filing and the company’s commitment to finalize its annual report.
The most recent analyst rating on (GOVX) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on GeoVax Labs stock, see the GOVX Stock Forecast page.
Spark’s Take on GOVX Stock
According to Spark, TipRanks’ AI Analyst, GOVX is a Neutral.
The score is held down primarily by weak financial performance (declining revenue, large losses, and sustained cash burn) and bearish technicals (below key moving averages with negative momentum). The main offset is the earnings-call catalyst around an expedited EMA development pathway and partnership interest, while valuation signals are limited due to negative earnings and no stated dividend.
To see Spark’s full report on GOVX stock, click here.
More about GeoVax Labs
Average Trading Volume: 140,665
Technical Sentiment Signal: Sell
Current Market Cap: $3.02M
Learn more about GOVX stock on TipRanks’ Stock Analysis page.